Search
Janux Therapeutics Inc
JANXAdd to Watchlist
15.170USD
-0.410-2.63%
Close 07-31 16:00（ET）Quotes delayed by 15 min
925.13MMarket Cap
LossP/E TTM
Janux Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Janux Therapeutics Inc is 7.76, ranking 145 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -8.24, which is -51.53% below the recent high of -3.99 and -593.39% above the recent low of -57.11.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.